Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity
Open Access
- 3 August 2005
- journal article
- fast track
- Published by Wiley in International Journal of Cancer
- Vol. 118 (2), 274-278
- https://doi.org/10.1002/ijc.21401
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Melatonin–estrogen interactions in breast cancerJournal of Pineal Research, 2005
- Melatonin and mammary cancer: a short review.Endocrine-Related Cancer, 2003
- Calmodulin Is a Selective Modulator of Estrogen ReceptorsMolecular Endocrinology, 2002
- Melatonin as a Chronobiotic / Anticancer Agent: Cellular, Biochemical, and Molecular Mechanisms of Action and their Implications for Circadian-Based Cancer TherapyCurrent Topics in Medicinal Chemistry, 2002
- Melatonin and Mammary Pathological GrowthFrontiers in Neuroendocrinology, 2000
- Aromatase in Aging WomenSeminars in Reproductive Medicine, 1999
- Melatonin increases p53 and p21WAFl expression in MCF-7 human breast cancer cells in vitroLife Sciences, 1999
- Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatoninLife Sciences, 1996
- The immunoneuroendocrine role of melatoninJournal of Pineal Research, 1993
- Effects of melatonin on the cell cycle kinetics and “estrogen‐rescue” of MCF‐7 human breast cancer cells in cultureJournal of Pineal Research, 1991